We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Innovative Techniques Devised for Characterizing Proteins

By LabMedica International staff writers
Posted on 28 Oct 2010
Utilizing a combination of high-powered computers and sophisticated research magnetic resonance (MR) data, a U.S. More...
biophysical chemist has developed techniques that enhance the manner in which scientists can examine and predict the structure and dynamics of proteins found in the human body. These developments could eventually shorten the time it takes researchers to develop new, more effective drugs and better understand biomedical processes that underlie a host of health disorders.

The new techniques "allow us to more accurately understand protein behavior and function at all levels, how enzymes work, and how to develop drugs that bind to certain proteins,” said Dr. Rafael Brüschweiler, a professor in Florida State University's (FSU; Tallahassee, USA) department of chemistry and biochemistry and associate director for biophysics at the U.S. National High Magnetic Field Laboratory at the FSU.

Given that there are hundreds of thousands of different proteins found in the human body, advances such as Dr. Brüschweiler's that can streamline their analysis and understanding are viewed as most desirable in the scientific community.

Over the past several years, Dr. Brüschweiler and his colleagues have incorporated a pair of complementary but powerful tools, both of which provide detailed data about the structure and dynamics of proteins at the atomic level. Nuclear magnetic resonance (NMR) data are first collected for a specific protein that is being analyzed. NMR is a research tool that utilizes high magnetic fields to measure the strengths, directions, and temporary fluctuations of magnetic interactions between the atoms in a protein fragment.

Subsequently, in a technique Dr. Brüschweiler has developed, high-powered computers are used to confirm the NMR data in terms of their realistic representation of protein structure and dynamics, as well as to make additional predictions of those characteristics.

The computational results significantly rely on the shape of the protein's "energy landscape,” the conformational space available to that protein under physiologic conditions. However, due to its intricacy, improving characterizations of the energy landscape is a difficult and time-consuming undertaking. In fact, until recently, a computer simulation of a single protein that represented just a microsecond took several months. Now, with the aid of the powerful computer array at Florida State's High Performance Computing Center, it takes Dr. Brüschweiler and his group only a fraction of the time it once did.

Working with a postdoctoral associate, Da-Wei Li, Brüschweiler has found a highly effective way to use directly the NMR information for improving the protein potential. The basic idea is to "recycle” an existing simulation of an intact protein, using methods taken from statistical physics, for many trial potentials until the one is found that yields the best agreement with experiment. This leads to an increase in speed by a factor of 100,000 or more over previous techniques. The approach is not only efficient but also permits the improvement of the protein potential directly on intact proteins, instead of on small fragments, as was previously the case.

"This has opened up a new way of becoming increasingly quantitative in our computations, which is key in developing a predictive understanding of the functions of proteins,” Dr. Brüschweiler said.

An article describing the research was published online August 16, 2010, in the journal Angewandte Chemie. "This is the culmination of a number of years of research on our part, so obviously we're excited about the progress we have made,” Dr. Brüschweiler said. "While this is fairly basic research designed to develop a greater understanding of life at a molecular level, it opens up a range of possibilities for future advances by scientists all over the world.”

Related Links:
Florida State University



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.